KR860001507B1 - 5-(치환된 페닐) 히단토인의 제조방법 - Google Patents

5-(치환된 페닐) 히단토인의 제조방법 Download PDF

Info

Publication number
KR860001507B1
KR860001507B1 KR1019830005157A KR830005157A KR860001507B1 KR 860001507 B1 KR860001507 B1 KR 860001507B1 KR 1019830005157 A KR1019830005157 A KR 1019830005157A KR 830005157 A KR830005157 A KR 830005157A KR 860001507 B1 KR860001507 B1 KR 860001507B1
Authority
KR
South Korea
Prior art keywords
chloro
alkyl
hydantoin
hydrogen
fluoro
Prior art date
Application number
KR1019830005157A
Other languages
English (en)
Korean (ko)
Other versions
KR840006630A (ko
Inventor
피. 리지 제임스
씨. 쉬너 로드니
Original Assignee
화이자 인코포레이티드
테렌스 제이. 겔라거
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 화이자 인코포레이티드, 테렌스 제이. 겔라거 filed Critical 화이자 인코포레이티드
Publication of KR840006630A publication Critical patent/KR840006630A/ko
Application granted granted Critical
Publication of KR860001507B1 publication Critical patent/KR860001507B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019830005157A 1982-11-01 1983-10-31 5-(치환된 페닐) 히단토인의 제조방법 KR860001507B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US438,199 1982-11-01
US438199 1982-11-01
US06/438,199 US4452806A (en) 1982-11-01 1982-11-01 Treating diabetic complications with 5-(substituted phenyl)hydantoins

Publications (2)

Publication Number Publication Date
KR840006630A KR840006630A (ko) 1984-12-01
KR860001507B1 true KR860001507B1 (ko) 1986-09-30

Family

ID=23739660

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830005157A KR860001507B1 (ko) 1982-11-01 1983-10-31 5-(치환된 페닐) 히단토인의 제조방법

Country Status (13)

Country Link
US (1) US4452806A (sv)
JP (1) JPS5998063A (sv)
KR (1) KR860001507B1 (sv)
CA (1) CA1203241A (sv)
DK (1) DK158724C (sv)
ES (1) ES8507119A1 (sv)
FI (1) FI80265C (sv)
GR (1) GR79638B (sv)
HU (1) HU191887B (sv)
PL (1) PL139646B1 (sv)
PT (1) PT77578A (sv)
YU (1) YU43556B (sv)
ZA (1) ZA838092B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1321980A4 (en) 2000-09-25 2007-04-04 Ibiden Co Ltd SEMICONDUCTOR ELEMENT, METHOD FOR MANUFACTURING SEMICONDUCTOR ELEMENT, MULTILAYER PRINTED CIRCUIT BOARD, AND METHOD FOR MANUFACTURING MULTILAYER PRINTED CIRCUIT BOARD
IT1319201B1 (it) * 2000-10-12 2003-09-26 Nicox Sa Farmaci per il diabete.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4189587A (en) * 1977-04-05 1980-02-19 Ciba-Geigy Corporation 1,3-Diaminomethyl-hydantoin additives for lubricating oils
FR2458546A1 (fr) * 1979-06-07 1981-01-02 Hoechst France Procede de fabrication d'aryl-5 hydantoines racemiques et produits nouveaux en resultant

Also Published As

Publication number Publication date
FI833993A0 (fi) 1983-10-31
DK158724C (da) 1990-11-19
JPH0465832B2 (sv) 1992-10-21
DK499983A (da) 1984-05-02
PT77578A (en) 1983-11-01
HU191887B (en) 1987-04-28
FI80265C (sv) 1990-05-10
PL244350A1 (en) 1985-02-13
FI80265B (fi) 1990-01-31
KR840006630A (ko) 1984-12-01
PL139646B1 (en) 1987-02-28
ES526841A0 (es) 1985-05-01
ZA838092B (en) 1985-06-26
JPS5998063A (ja) 1984-06-06
CA1203241A (en) 1986-04-15
DK158724B (da) 1990-07-09
US4452806A (en) 1984-06-05
DK499983D0 (da) 1983-11-01
FI833993A (fi) 1984-05-02
YU216783A (en) 1986-02-28
YU43556B (en) 1989-08-31
GR79638B (sv) 1984-10-31
ES8507119A1 (es) 1985-05-01

Similar Documents

Publication Publication Date Title
EP0193256B1 (en) Thiazolidinedione derivatives, their production and use
US20060004062A1 (en) Compounds for inhibiting insulin secretion and methods related thereto
EP0138464A2 (en) 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
LU84561A1 (fr) 2-(4-((4,4,-dialcoyl-2,6-piperidinedione-1-yl)butyl)-1-piperazinyl)pyrimidines
LU85442A1 (fr) Agents antidepression a base de 1,2,4-triazol-3-one
CZ397598A3 (cs) Derivát 5-fenoxyalkyl-2,4-thiazolidindionu, způsob jeho přípravy, meziprodukty pro jeho přípravu a farmaceutický prostředek, který ho obsahuje
HU199839B (en) Process for producing new 1',2'-dihydro-spiro square brackets open imidazolidine-4,4'(3'h)-quinoline square brackets closed derivatives and pharmaceutical compositions comprising same as active ingredient
IL42640A (en) Substituted 2'-phenoxyalkane-sulfonanilides
JPH0390062A (ja) 置換ｎ―（キノリン―２―イル―メトキシ）ベンジルスルホニルウレア
KR860001507B1 (ko) 5-(치환된 페닐) 히단토인의 제조방법
AU638878B2 (en) New benzoselenazolinone compounds, process for preparing these and pharmaceutical compositions containing them
JPS61277671A (ja) アルド−ス還元酵素阻害剤としてのスピロ−イミダゾリジン類
US4673677A (en) Method for treatment of gastrointestinal disorders
CA1244443A (en) Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications
KR860001508B1 (ko) 5-(2-알콕시-3-치환된 페닐) 히단토인의 제조방법
EP0112620B1 (en) 5-(substituted phenyl) hydantoins
US3803165A (en) N-(2-(2-nitro-1-imidazolyl)ethyl)-2',2',2'-trichloroethyl carbamate
KR870000625B1 (ko) 스피로-헤테로아졸론의 제조방법
IE920979A1 (en) Pyridazinone acetic acids
AU610629B2 (en) Improvements in or relating to leukotriene antagonists
US4200760A (en) Imidazolylalkylthioalkylamino-ethylene derivatives
JP2816974B2 (ja) ベンズイミダゾール誘導体およびその製造法ならびにこれを含有する抗潰瘍剤
EP0877026B1 (en) Substituted 6-r-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them
PL163654B1 (pl) Sposób wytwarzania nowych pochodnych imidazoiu PL PL PL
JPS63255223A (ja) 抗潰瘍剤

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19920708

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee